Network Search

Search results

Your search for zyprexa returned 74 results from seattletimes.com.

Search
Row number Title link and text description Topic category
1 Lechleiter pay rises in 1st full year as Lilly CEO Business
...selling drugs including the anti-psychotic Zyprexa and the antidepressant Cymbalta. Lechleiter...more than $1 billion in sales, led by Zyprexa's $4.9 billion. But analysts...key drugs expire in the next few years. Zyprexa's patent expires next year. The...
2/8/2010 | seattletimes.com | find similar results
2 Miss. settles Zyprexa suit for more than $18M Business
...company promoted the anti-psychotic Zyprexa for ailments it was not federally approved...Mississippi is one of 13 states that sued over Zyprexa. Eli Lilly spokeswoman Marni Lemons said...January 2009 after admitting it had promoted Zyprexa in elderly populations for treatment of...
2/4/2010 | seattletimes.com | find similar results
3 Drugmakers post higher sales but a mix on profits Business
...switch" as soon as a new one comes out?" Bannister said. Still, Lilly did OK because its top seller, antipsychotic drug Zyprexa, had double-digit sales growth to $1.36 billion, and its No. 2 drug, antidepressant Cymbalta, rose 15 percent to...
1/28/2010 | seattletimes.com | find similar results
4 Eli Lilly reports 4Q profit, Effient sales drop Business
...established products, including its top-seller, the antipsychotic Zyprexa. However, sales of Lilly's widely anticipated blood...Lilly drugs rang up more than $1 billion in sales, led by Zyprexa's $4.9 billion. For the full year, Lilly earned...
1/28/2010 | seattletimes.com | find similar results
5 Investigators say price hikes on drugs increasing Business
...medications but also include some popular products like Bayer's antibiotic Cipro and the Eli Lilly schizophrenia treatment Zyprexa. The Government Accountability Office report issued Monday attributed the rise to a combination of factors, including...
1/11/2010 | seattletimes.com | find similar results
6 FDA cancels meeting to review Lilly's Cymbalta Business
...second-best selling product, behind the anti-psychotic Zyprexa. Cymbalta generated $2.24 billion in sales through the...selling drugs in the next few years. The patent protecting Zyprexa, which generated more than $4 billion in 2008, expires in...
1/5/2010 | seattletimes.com | find similar results
7 FDA OKs longer-lasting version of Lilly's Zyprexa Business
...top-selling drug, the anti-psychotic Zyprexa. The Food and Drug Administration approved Zyprexa Relprevv, an injection that can last up...schizophrenia in adults. Patients on Zyprexa currently take a pill daily. Lilly also...
12/14/2009 | seattletimes.com | find similar results
8 Eli Lilly predicts earnings growth, touts pipeline Business
...sold into the future." Lilly will lose patent protection for its best-selling drug, the antipsychotic Zyprexa, in 2011. Zyprexa generated $4.7 billion in sales last year. In 2013 and 2014, Lilly will lose protection for four drugs...
12/10/2009 | seattletimes.com | find similar results
9 AG says Utah agrees to $24M Zyprexa settlement Business
...marketing of the anti-psychotic drug Zyprexa, Utah Attorney General Mark Shurtleff said Wednesday. Zyprexa is approved for the treatment of schizophrenia...company's sales force illegally promoted Zyprexa for uses not approved by the Food and...
11/11/2009 | seattletimes.com | find similar results
10 Alarming weight gain seen in kids on psych drugs Health and Family
...from 10 percent to 36 percent became obese. The drugs are Abilify, Risperdal, Seroquel and Zyprexa. Of the four, Seroquel and Zyprexa are not yet approved for children, and they had the worst effects on weight and cholesterol. However...
10/27/2009 | seattletimes.com | find similar results
11 APNewsBreak: SC AG reaches $45M deal with Lilly Business
...was its largest with a single state over Zyprexa. "This is a victory for South Carolina...based drug maker had improperly marketed Zyprexa for off-label uses. The Food and Drug...in 44 other states have sued Lilly over Zyprexa, but the $45 million agreement is the...
10/23/2009 | seattletimes.com | find similar results
12 Eli Lilly CEO banking on new drug pipeline Business
...early in the next decade. Q. You're facing patent expirations for your two best-selling drugs, the antipsychotic Zyprexa and the antidepressant Cymbalta, and other blockbusters. You think your pipeline can replace what they generate? A...
10/22/2009 | seattletimes.com | find similar results
13 Lilly posts 3Q profit; analysts doubt future sales Business
...Its top-seller, the anti-psychotic Zyprexa, brought in $1.2 billion, or 3 percent...analyst Seamus Fernandez said. But Zyprexa's patent expires in 2011, and protection...settle government investigations into Zyprexa marketing. Revenue grew to $5.56...
10/21/2009 | seattletimes.com | find similar results
14 Earnings Preview: Bristol-Myers 3Q earnings report Business
...competitors include Pfizer Inc.'s Geodon, Johnson & Johnson's Risperdal, AstraZeneca PLC's Seroquel and Eli Lilly & Co.'s Zyprexa. The drugs have combined sales of well over $15 billion a year. On the upside, the FDA in July approved Onglyza, a...
10/21/2009 | seattletimes.com | find similar results
15 Conn. gets $25 million from Zyprexa lawsuit Business
...over claims the drugmaker marketed its anti-psychotic drug Zyprexa for unapproved uses and harmed patients. Attorney General Richard Blumenthal says federal regulators approved Zyprexa for schizophrenia and bipolar disorder. But he says the...
9/29/2009 | seattletimes.com | find similar results
16 Lilly to cut 14 pct of staff, trim $1B in costs Business
...Meanwhile, key Lilly products like the anti-psychotic drug Zyprexa will lose patent protection starting in 2011, with three other...drug Erbitux and help balance the revenue it would lose when Zyprexa, Cymbalta, Humalog and Gemzar faced generic competition...
9/14/2009 | seattletimes.com | find similar results
17 Record fine unlikely to end bogus drug marketing Business
...case over the marketing of its top seller Zyprexa, an anti-psychotic drug. Court...millions of dollars" through off-label Zyprexa promotions, but it's hard to pin down the exact impact of improper marketing. Zyprexa's annual U.S. sales nearly doubled...
9/4/2009 | seattletimes.com | find similar results
18 Schering-Plough gets FDA approval for Saphris Business
...Abilify, Pfizer Inc.'s Geodon, Johnson & Johnson's Risperdal, AstraZeneca PLC's Seroquel and Eli Lilly & Co.'s Zyprexa. Those five drugs had nearly $16 billion in combined revenue last year, although some involved prescriptions for uses not...
8/14/2009 | seattletimes.com | find similar results
19 Eli Lilly shares on Goldman analyst downgrades Business
...based company stands to lose almost $10 billion in sales between 2010 and 2015 as patents expire on the anti-psychotic Zyprexa, antidepressant Cymbalta, the insulin Humalog, and others. He also lowered his 12-month price target to $30 from...
8/10/2009 | seattletimes.com | find similar results
20 Lilly makes buyout offer to 4,000 sales reps Business
...Wisconsin. The company's best-selling drugs include Zyprexa for schizophrenia and bipolar disorder, Cymbalta for depression...diabetes, and Evista for osteoporosis. The patent supporting Zyprexa, which bought in $4.7 billion in revenue last year, is...
8/4/2009 | seattletimes.com | find similar results